Developmental evaluation of aldo-keto reductase 1C3 expression in the cryptorchid testis

Urology

Volumn 76, Issue 1, 2010, Pages 67-72

  Ashley, Richard A ^a,b,c   Yu, Zhongxin ^a,b,c   Fung, Kar Ming ^a,b,c   Frimberger, Dominic ^a,b,c   Kropp, Bradley P ^a,b,c   Penning, Trevor M ^a,b,c   Lin, Hsueh Kung ^a,b,c  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDO KETO REDUCTASE 1C3; OXIDOREDUCTASE; UNCLASSIFIED DRUG; 15 HYDROXYPROSTAGLANDIN DEHYDROGENASE; 3(OR 17)BETA HYDROXYSTEROID DEHYDROGENASE; AKR1C3 PROTEIN, HUMAN;

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; CRYPTORCHISM; EXCISION; GERM CELL; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LEYDIG CELL; MALE; ORCHIECTOMY; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHOOL CHILD; SERTOLI CELL; SPERMATIC CORD; TESTIS ATROPHY; BIOSYNTHESIS; ENZYMOLOGY; INFANT; PUBERTY;

3-HYDROXYSTEROID DEHYDROGENASES; ADOLESCENT; CHILD; CHILD, PRESCHOOL; CRYPTORCHIDISM; HUMANS; HYDROXYPROSTAGLANDIN DEHYDROGENASES; INFANT; MALE; PUBERTY;

EID: 77955889830     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2009.09.046     Document Type: Article

References (23)

1. Penning TM, Burczynski ME, Jez JM, et al. Human 3a-hydroxysteroid dehydrogenase isoforms (AKR1C1-AKR1C4) of the aldoketo reductase superfamily: Functional plasticity and tissue distribution reveals roles in the inactivation and formation of male and female sex hormones. Biochem J. 2000;351:67-77.
2. Lin HK, Jez JM, Schlegel BP, et al. Expression and characterization of recombinant type 2 3a-hydroxysteroid dehydrogenase (HSD) from human prostate: Demonstration of bifunctional 3a/17b-HSD activity and cellular distribution. Mol Endocrinol. 1997;11:1971-1984. (Pubitemid 27524880)
3. Matsuura K, Shiraishi H, Hara A, et al. Identification of a principal mRNA species for human 3a-hydroxysteroid dehydrogenase isoform (AKR1C3) that exhibits high prostaglandin D2 11-ketoreductase activity. J Biochem (Tokyo). 1998;124:940-946. (Pubitemid 28544904)
4. Lewis MJ, Wiebe JP, Heathcote JG. Expression of progesterone metabolizing enzyme genes (AKR1C1, AKR1C2, AKR1C3, SRD5A1, SRD5A2) is altered in human breast carcinoma. BMC Cancer. 2004;4:27.
5. Rizner TL, Smuc T, Rupreht R, et al. AKR1C1 and AKR1C3 may determine progesterone and estrogen ratios in endometrial cancer. Mol Cell Endocrinol. 2006;248:126-135.
6. Fung KM, Samara ENS, Wong C, et al. Increased expression of type 2 3a-hydroxysteroid dehydrogenase/type 5 17b-hydroxysteroid dehydrogenase (AKR1C3) and its relationship with androgen receptor in prostate carcinoma. Endocr Relat Cancer. 2006;13:169-180.
7. Wako K, Kawasaki T, Yamana K, et al. Expression of androgen receptor through androgen-converting enzymes is associated with biological aggressiveness in prostate cancer. J Clin Pathol. 2008;61: 448-454. (Pubitemid 351518226)
8. Azzarello J, Fung KM, Lin HK. Tissue distribution of human AKR1C3 and rat homolog in adult genitourinary system. J Histochem Cytochem. 2008;56:853-861.
9. Hughes IA, Acerini CL. Factors controlling testis descent. Eur J Endocrinol. 2008;159(suppl 1):S75-S82.
10. Lin HK, Steckelbroeck S, Fung KM, et al. Characterization of a monoclonal antibody for human aldo-keto reductase AKR1C3 (type 2 3a-hydroxysteroid dehydrogenase/type 5 17b-hydroxysteroid dehydrogenase); immunohistochemical detection in breast and prostate. Steroids. 2004;69:795-801. (Pubitemid 39593392)
11. Roth CC, Bell CH, Woodson B, et al. Temporal differentiation and maturation of regenerated rat urothelium. BJU Int. 2008;103:836-841.
12. Bauman DR, Steckelbroeck S, Peehl DM, et al. Transcript profiling of the androgen signal in normal prostate, benign prostatic hyperplasia, and prostate cancer. Endocrinology. 2006;147:5806-5816. (Pubitemid 44833497)
13. Labrie F, Luu-The V, Lin SX, et al. The key role of 17 b-hydroxysteroid dehydrogenases in sex steroid biology. Steroids. 1997;62: 148-158. (Pubitemid 27066999)
14. Andersson S, Geissler WM, Wu L, et al. Molecular genetics and pathophysiology of 17b-hydroxysteroid dehydrogenase 3 deficiency. J Clin Endocrinol Metab. 1996;81:130-136. (Pubitemid 26035013)
15. Leihy MW, Shaw G, Renfree MB, et al. Administration of 5aandrostane-3a,17a-diol to female tammar wallaby pouch young causes development of a mature prostate and male urethra. Endocrinology. 2002;143:2643-2651. (Pubitemid 34704642)
16. Sharpe RM, McKinnell C, Kivlin C, et al. Proliferation and functional maturation of Sertoli cells, and their relevance to disorders of testis function in adulthood. Reproduction. 2003;125:769-784. (Pubitemid 36722545)
17. Cederroth CR, Schaad O, Descombes P, et al. Estrogen receptor alpha is a major contributor to estrogen-mediated fetal testis dysgenesis and cryptorchidism. Endocrinology. 2007;148:5507-5519. (Pubitemid 350012657)
18. Hadziselimovic F, Girard J. Pathogenesis of cryptorchidism. Horm Res. 1977;8:76-83. (Pubitemid 8171680)
19. Wang S, Yang Q, Fung KM, et al. AKR1C2 and AKR1C3 mediated prostaglandin D2 metabolism augments the PI3K/Akt proliferative signaling pathway in human prostate cancer cells. Mol Cell Endocrinol. 2008;289:60-66.
20. Schell C, Frungieri MB, Albrecht M, et al. A prostaglandin D2 system in the human testis. Fertil Steril. 2007;88:233-236. (Pubitemid 47001389)
21. Sorrentino C, Silvestrini B, Braghiroli L, et al. Rat prostaglandin D2 synthetase: Its tissue distribution, changes during maturation, and regulation in the testis and epididymis. Biol Reprod. 1998; 59:843-853. (Pubitemid 28463336)
22. Cooper DR, Carpenter MP. Sertoli-cell prostaglandin synthesis. Effects of (follitropin) differentiation and dietary vitamin E. Biochem J. 1987;241:847-855. (Pubitemid 17000737)
23. Russell TR, Ho R. Conversion of 3T3 fibroblasts into adipose cells: Triggering of differentiation by prostaglandin F2a and 1-methyl-3-isobutyl xanthine. Proc Natl Acad Sci U S A. 1976;73:4516-4520. (Pubitemid 8013931)